References
- Huehns ER. Diseases due to abnormalities of hemoglobin structure. Annu Rev Med. 1970;21:157–178.
- Hardison RC, Chui DHK, Giardine B, et al. HbVar: a relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat. 2002;19(3):225–233. Available from: http://globin.cse.psu.edu.
- Kyrri A, Felekis X, Kalogerou E, et al. Hb Limassol [β8(A5)Lys→Asn]: a new hemoglobin variant. Hemoglobin. 2001;25(4):421–424.
- Purohit P, Mashon RS, Patel S, et al. Clinical and molecular characterization of Hb Hofu in eastern India. Int J Lab Hematol. 2014;36(1):71–76.
- Meher S, Dehury S, Mohanty PK, et al. Hb Tianshui (HBB: C.119A>G) in compound heterozygosity with Hb S (HBB: C.20A>T) from Odisha, India. Hemoglobin. 2016;40(4):270–272.
- Patel S, Purohit P, Mashon RS, et al. The effect of hydroxyurea on compound heterozygotes for sickle cell-hemoglobin D-Punjab – a single centre experience in eastern India. Pediatr Blood Cancer. 2014;61(8):1341–1346.
- Dehury S, Purohit P, Patel S, et al. Low and fixed dose of hydroxyurea is effective and safe in patients with HbSβ+ thalassemia with IVS1-5(G→C) mutation. Pediatr Blood Cancer. 2015;62(6):1017–1023.